The U.S. Food and Drug Administration (FDA) likely overstepped its authority when it told Americans to “stop” using ivermectin against COVID-19, a federal court ruled on Sept. 1.
“FDA can inform, but it has identified no authority allowing it to recommend consumers ‘stop’ taking medicine,” U.S. Circuit Judge Don Willett wrote in the ruling.
The FDA has authority under the Federal Food, Drug, and Cosmetic Act to convey information to consumers.
The FDA during the COVID-19 pandemic issued multiple statements discouraging people from taking ivermectin against COVID-19.